Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
ID number 10020
Description Digital health technologies are available that could assist in the management of psychosis. These technologies work in different ways and may be useful in both early intervention and long-term care of psychosis. Psychosis is a state of mind where a person’s abilities to understand and test reality are impaired. Management of psychosis usually involves an early intervention in psychosis (EIP) specialist team for the first episode, or a specialist community mental health team (CMHT) for longer-term psychosis. Acute episodes of psychosis may require psychiatric hospitalisation. A person with psychosis could be discharged back to their GP if they have been stable and symptom-free for a long time. Current practice for treatment of psychosis is with an antipsychotic medication. Cognitive behavioural therapy is less commonly used despite evidence for its effectiveness. The use of antipsychotic medication is a contributor to poor physical health in this patient group and there is a need to provide non-drug interventions which avoid these side-effects. There is widespread regional variation in speed of access to therapeutic interventions, particularly psychological interventions. An area of priority is enabling access to approved interventions quickly after diagnosis, as early intervention improves the overall trajectory of prognosis. The demand for psychological therapy in particular outstrips the capacity to provide this in a timely manner, and thus a range of options would be helpful to provide a psychological intervention. Digital health technologies may help in enabling access to non-drug interventions which improve outcomes including health related quality of life and wellbeing. The NICE HealthTech Programme will conduct an early value assessment of digital health technologies for management of psychosis. The assessment will map the evidence that is available on the technologies, assess their potential clinical and cost-effectiveness and identify evidence gaps to help direct data generation.

Provisional Schedule

Expected publication 21 March 2024

Project Team

Project lead Catherine Pank

Email enquiries


Key events during the development of the guidance:

Date Update
18 January 2024 - 01 February 2024 Draft guidance
04 September 2023 Scope published
10 July 2023 Launch
04 July 2023 In progress. In progress
04 May 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our early value assessment interim statement.